Emilie Olié, MD, PhD
- 12Articles
- 59.2KReads
- 2014–2025Active
- 50Collaborators
- 865Citations
About
Emilie Olié, MD, PhD, is affiliated with the Department of Emergency Psychiatry and Post-Acute Care at CHU Montpellier and IGF, University of Montpellier, CNRS-INSERM in France. Olié has published extensively on suicide, bipolar disorder, major depressive disorder, COVID-19-related mental health issues, and somatoform disorders. Research topics include the effects of ketamine on suicidal crises, bright light therapy for bipolar depression, suicidal risk assessment, psychological pain in suicidality, and the interplay of inflammation and brain connectivity in depression. Olié has contributed to 12 articles between 2014 and 2025 in peer-reviewed journals.
Publications
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
June 23, 2025
The Need to Assess Suicidal Risk When Prescribing Opioids
December 28, 2016
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.